• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.31% Nasdaq Up 1.75%

    InVivo Therapeutics Holdings Corp. (NVIV)

    -NasdaqGM
    3.88 Up 0.16(4.30%) 12:52PM EST - Nasdaq Real Time Price
    Prev Close:3.72
    Open:3.82
    Bid:3.84 x 700
    Ask:3.87 x 500
    1y Target Est:25.00
    Beta:2.82534
    Next Earnings Date:N/A
    Day's Range:3.70 - 3.94
    52wk Range:3.50 - 19.68
    Volume:104,997
    Avg Vol (3m):323,529
    Market Cap:106.15M
    P/E (ttm):N/A
    EPS (ttm):-1.46
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVIV

    Comparison

    Symbol% ChgMkt Cap
    NVIVUp 4.30%106.15M
    ALSE 0.00%398.26K
    ACORUp 3.17%1.57B
    STEMDown 0.82%34.29M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :N/A
    Quarterly EPS Est (Sep-15) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Invivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injury (SCI). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback